Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

<div>The ROC value of the prognostic model. (a) The ROC curves of OS in the TCGA training dataset. (b) The ROC curves of OS in the TCGA testing dataset.</div>

Analytical Cellular Pathology

fig4

Figure 4

Figure 4: Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 

Figure 4 | Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma 